Expanded Access Study With Peginterferon Alfa-2a (Pegasys) in Participants With Chronic Myelogenous Leukemia (CML)

Clinical trial NCT02736721 · COMPLETED

Trial details

NCT number: NCT02736721
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Myelogenous Leukemia, Chronic

Start date: 2003-09-01
Primary completion: 2010-11-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.